Frontlight ResearchEarly access
Taking people in United KingdomNo phase
Body Clock Type and Blood Sugar Control in People With Diabetes
Studies how body clock type relates to blood sugar control in adults with diabetes.
Key facts
- Who runs it
- University of Leicester
- Where
- Leicester, United KingdomSee the site
- Trial code
- Registry title
- Chronotype of Patients With Diabetes and Effect on Glycaemic Control
- Status
- Recruiting
- People taking part
- 3,447 people, planned
- Started
- 7 Dec 2016
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Record updated
- 15 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 1 or long-standing type 2 diabetes to study how body clock type (chronotype) relates to blood sugar control.
- Age
- 18 to 75 years
- Sex
- Men and women can both join.
- Disease stage
- Type 1 diabetes, or type 2 diabetes diagnosed more than 6 months ago.
- Earlier treatment
- On any glucose-lowering treatment, or lifestyle changes for type 2 diabetes.
Main reasons for not taking part
- BMI above 45 kg/m²
- Sleep disorder other than obstructive sleep apnoea
- Weekly cannabis use
- Terminal illness
- Weekly use of wakefulness drugs, sedatives, melatonin or clonazepam
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Participant is willing and able to give informed consent for participation in the study
- T1DM or established T2DM (>6months since diagnosis)
- Male or Female
- Aged 18-75 years inclusive
- BMI less than or equal to 45kg/m² inclusive
- No known sleep disorders except Obstructive Sleep Apnoea (OSA)
- On any glucose-lowering therapy (T1DM or T2DM) or lifestyle modification for management of T2DM
- Good command of the English language
Who cannot take part
- Have a terminal illness
- A known sleep disorder that is not OSA
- Regular use of the following medicines i.e. Weekly use: (Wakefulness promoting agents Modafinil, Amphetamine derivatives, Methylphenidate; Sedatives including benzodiazepines, Z-drugs (zopiclone, zolpidem \& zaleplon); Melatonin, including Circadin and melatonin analogues; Clonazepam and other drugs for nocturnal movement disorders)
- Anyone <18 years of age and >75 years of age
- Participant is unwilling or unable to give informed consent
- Anyone without a good command of the English language
- BMI greater than 45 kg/m²
- A regular cannabis user i.e. weekly use
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United Kingdom
- Leicester Diabetes Centre, Leicester General HospitalLeicester, United KingdomContact: Sahar Khodabakhsh, PhDTaking people
About the trial
What the trial wants to find out
The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Chronotype of Patients With Diabetes and Effect on Glycaemic Control: The CODEC Study
- Plain-language title
- Body Clock Type and Blood Sugar Control in People With DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT02973412, who can take part
- Publications
- Self-compassion, sleep quality and psychological well-being in type 2 diabetes: a cross-sectional study.BMJ open diabetes research & care, 2022
- Physical behaviors and chronotype in people with type 2 diabetes.BMJ open diabetes research & care, 2020
- Rationale and design of a cross-sectional study to investigate and describe the chronotype of patients with type 2 diabetes and the effect on glycaemic control: the CODEC study.BMJ open, 2019
- Record updated
- 15 February 2024